| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| GTO ID | GTC3812 |
| Trial ID | NCT06326021 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | FL-33 CAR T |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia：a Single-center, Open-label, Non-randomised, Single-arm Phase I Clinical Trial |
| Year | 2024 |
| Country | China |
| Company sponsor | Beijing GoBroad Hospital |
| Other ID(s) | BJGBYY-IIT-LCYJ-2024-004 |
| Cohort 1 | |||||||||
|
|||||||||